BEAM
Price
$17.82
Change
+$0.19 (+1.08%)
Updated
Aug 15 closing price
Capitalization
1.8B
85 days until earnings call
CELC
Price
$51.79
Change
-$0.10 (-0.19%)
Updated
Aug 15 closing price
Capitalization
2.13B
92 days until earnings call
Interact to see
Advertisement

BEAM vs CELC

Header iconBEAM vs CELC Comparison
Open Charts BEAM vs CELCBanner chart's image
Beam Therapeutics
Price$17.82
Change+$0.19 (+1.08%)
Volume$2.15M
Capitalization1.8B
Celcuity
Price$51.79
Change-$0.10 (-0.19%)
Volume$908.87K
Capitalization2.13B
BEAM vs CELC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CELC commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CELC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (BEAM: $17.82 vs. CELC: $51.79)
Brand notoriety: BEAM and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 93% vs. CELC: 67%
Market capitalization -- BEAM: $1.8B vs. CELC: $2.13B
BEAM [@Biotechnology] is valued at $1.8B. CELC’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCELC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CELC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CELC is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +1.14% price change this week, while CELC (@Biotechnology) price change was +12.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.13B) has a higher market cap than BEAM($1.8B). CELC YTD gains are higher at: 295.646 vs. BEAM (-28.145). CELC has higher annual earnings (EBITDA): -114.96M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CELC (206M). CELC has less debt than BEAM: CELC (98.7M) vs BEAM (158M). BEAM has higher revenues than CELC: BEAM (63.6M) vs CELC (0).
BEAMCELCBEAM / CELC
Capitalization1.8B2.13B85%
EBITDA-399.03M-114.96M347%
Gain YTD-28.145295.646-10%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B206M592%
Total Debt158M98.7M160%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCELC
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGAX35.760.16
+0.45%
Gabelli Global Rising Income and Div A
CGVEX26.87-0.03
-0.11%
American Funds Global Insight 529-E
NGDRX31.55-0.04
-0.13%
Neuberger Berman Large Cap Growth R3
GISTX39.29-0.11
-0.28%
Goldman Sachs Technology Opps Inv
SVUIX39.88-0.14
-0.35%
NAA SMid Cap Value Institutional

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.08%
CRSP - BEAM
67%
Closely correlated
+1.55%
NTLA - BEAM
64%
Loosely correlated
+0.83%
RXRX - BEAM
64%
Loosely correlated
+2.30%
SYRE - BEAM
58%
Loosely correlated
+0.53%
DNLI - BEAM
57%
Loosely correlated
+1.66%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.19%
IMA - CELC
86%
Closely correlated
-3.99%
NEVPF - CELC
61%
Loosely correlated
N/A
BEAM - CELC
45%
Loosely correlated
+1.08%
CLDX - CELC
44%
Loosely correlated
+2.25%
ABOS - CELC
43%
Loosely correlated
+1.43%
More